Catalyst Pharmaceuticals (CPRX) Share-based Compensation Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.85% |
| Dec 31, 2025 | 30.97% |
| Sep 30, 2025 | 30.85% |
| Jun 30, 2025 | 33.46% |
| Mar 31, 2025 | 30.95% |
| Dec 31, 2024 | 35.09% |
| Sep 30, 2024 | 40.19% |
| Jun 30, 2024 | 36.65% |
| Mar 31, 2024 | 54.62% |
| Dec 31, 2023 | 32.78% |
| Sep 30, 2023 | 38.11% |
| Jun 30, 2023 | 33.03% |
| Mar 31, 2023 | 24.38% |
| Dec 31, 2022 | 31.73% |
| Sep 30, 2022 | 31.14% |
| Jun 30, 2022 | 25.94% |
| Mar 31, 2022 | 20.34% |
| Dec 31, 2021 | 24.68% |
| Sep 30, 2021 | 23.22% |
| Jun 30, 2021 | 33.55% |
| Mar 31, 2021 | 27.96% |
| Dec 31, 2020 | 20.58% |
| Sep 30, 2020 | 34.91% |
| Jun 30, 2020 | 37.58% |
| Mar 31, 2020 | 37.03% |
| Dec 31, 2019 | 31.93% |
| Sep 30, 2019 | 12.94% |
| Jun 30, 2019 | 110.15% |
| Mar 31, 2019 | 109.50% |
| Dec 31, 2018 | 89.13% |
| Sep 30, 2018 | 74.64% |
| Jun 30, 2018 | 77.53% |
| Mar 31, 2018 | 87.65% |
| Dec 31, 2017 | 18.90% |
| Sep 30, 2017 | 63.32% |
| Jun 30, 2017 | 69.91% |
| Mar 31, 2017 | 75.66% |
| Dec 31, 2016 | 14.44% |
| Sep 30, 2016 | 61.14% |
| Jun 30, 2016 | 40.58% |
| Mar 31, 2016 | 53.49% |
| Dec 31, 2015 | 18.56% |
| Sep 30, 2015 | 55.85% |